KDR and cancer: Furthermore, because most anti-angiogenic drugs are targeted towards angiogenic growth factors, their receptors, and their cellular signaling axes, cancer cells should not be directly affected (however, some cancer cells may express receptors found on ECs, such as VEGFR2) [59].